Overnight biosignal patterns and next-day MCAS symptoms

Many people with MCAS report that a bad night precedes a bad day. Continuous monitoring lets us look at what happens overnight, while the person is asleep and not logging anything.

Introduction

Nighttime is a gap in most symptom diaries, yet sleep disruption is one of the most frequently described features of MCAS. Passive overnight measurement can help fill that gap.

Methodology

We analyzed continuous overnight biosignals alongside next-day symptom reports, comparing nights against each participant’s own baseline.

Data collected:

• Overnight skin temperature and heart rate variability
• Movement and sleep-disruption indicators
• Next-day symptom logs
• Evening activity, meal and medication context

Results

Departures from a person’s typical overnight pattern were associated with higher next-day symptom burden for many participants, suggesting overnight data may carry early signal.

Clinical Implications

Overnight patterns could give earlier warning than daytime symptoms alone, and help clinicians understand the sleep disruption patients describe.

Conclusion

Overnight continuous monitoring captures information that daytime logs miss. Larger studies are needed to confirm how reliably it anticipates next-day symptoms.